A woman displays a pharmaceutical guide inside a clinic in Tay Ho, Vietnam. Photo by MSH staff.
Starting in the late 1980s, economic reforms and a dramatically improved business climate have allowed Vietnam to become one of the fastest-growing economies in the world. For example, the gross domestic product rose by at least 6.5 percent every year between 1990 and 2007. A shift away from a centrally planned economy to a more market-oriented economic model has improved the quality of life for many Vietnamese. In the past decade, Vietnamese industries have made large strides to increase exports of agricultural products and manufactured goods, leading to the rapid expansion of investment and trade opportunities for Vietnam’s global partners. Emphasis on democratic solidarity means that civil society is benefiting from the country’s economic successes. Basic health indicators reveal marked improvements in the general welfare of the populace, however, medical facilities in Vietnam frequently lack medicines and supplies, and preventable diseases such as malaria, tuberculosis, polio, and typhoid persist. Avian influenza and HIV also require urgent efforts if they are to be contained. While Vietnam has built an extensive grassroots health care network with the ability to address many of the country’s pressing concerns, the health care workforce lacks experience and expertise in strategic planning and policy implementation. MSH began providing technical assistance in 2005 for the management and distribution of the pharmaceuticals required for tuberculosis and HIV & AIDS patients. Strategic management of this pharmaceutical supply chain is the focus of MSH’s work in Vietnam. By implementing a practical approach at the provincial level, MSH has been able to work in concert with the Vietnamese health care work force and its supporters.  

Experience in this Country

MEASURE Evaluation

2008–2017

View Project Website

The MEASURE Evaluation project, which began in 1998, is USAID’s flagship Monitoring and Evaluation project and was established based on the premise that generating demand for and improving the use of data in policy formulation, program planning, monitoring and evaluation improves health systems which in turn affects health outcomes. The project is now in Phase III and is led by the University of North Carolina. In addition to MSH, the partners include Futures Group, JSI, Macro International , and Tulane University. MSH provides capacity building in the area of organization and leadership development to enhance sustainability using MSH’s virtual and other tools and also offers direct support to country M&E teams.

Supply Chain Management System Project

2006-2015

View Project Website

 SCMS (the Supply Chain Management System) supplies lifesaving medicines to HIV & AIDS programs around the world and is led by the Partnership for Supply Chain Management (a nonprofit organization established by MSH and JSI). The 17 SCMS international partners are hands-on and actively work to strengthen supply chains, enabling the scale-up of HIV & AIDS treatment in developing countries. SCMS is funded by the President's Emergency Plan for AIDS Relief to help deliver an uninterrupted supply of high-quality, affordable products including: antiretroviral drugs; drugs to treat opportunistic infections such as tuberculosis; and drugs and supplies for palliative and home-based care, HIV rapid test kits, and laboratory equipment. The project focuses on improving forecasting (to determine what drugs are really needed), aggregating demand and negotiating lower prices, and bringing the delivery mechanism closer to the point of use through regional warehouses. SCMS can work anywhere in the world, but is initially focused on the 15 Emergency Plan focus countries.

Rational Pharmaceutical Management Plus Program

2000–2008

View Project Website

MSH provided technical guidance and assists in strategy development and program implementation both in improving the availability of safe, effective health commodities of assured quality and cost—pharmaceuticals, laboratory diagnostics, vaccines, supplies, and basic medical equipment—and in promoting the appropriate use of these commodities in the public and private sectors at the community level, with special focus on managing pharmaceuticals essential for maternal, newborn, and child health.

Vietnam Country Map
 

Country Profile

County Profile
1 PRB 2006 World Population Datesheet
2 WHO Global Health Atlas
Population1 84,200,000
Infant Mortality Rate per 1,000 live births1 18.0 deaths/ 1,000 live births
Maternal Mortality Rate per 100,000 live births2
130/100,000 live births
HIV & AIDS Adult Prevalence1 0.5%
Population Living Below US$2 per day1 NA
Life Expectancy at Birth, Both Sexes1 72 yrs